InvestorsHub Logo
Post# of 252013
Next 10
Followers 60
Posts 11498
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 197623

Monday, 11/23/2015 8:10:37 PM

Monday, November 23, 2015 8:10:37 PM

Post# of 252013

During FY4Q15 (which predates any ABBV HCV sales in Japan), ENTA received V-Pak/Technivie/Viekirax royalties from ABBV at an annualized rate of $57M.



While these numbers might have some upside they certainly are dismal compared to the >$200m that was projected.

The market won't be there.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.